Abbott Stock Analysis


USD 104.81  0.95  0.91%   

The small drop in market price for the last few months could raise concerns from private investors as the firm is trading at a share price of 104.81 on 3,592,389 in volume. The company executives did not add much value to Abbott Laboratories investors in November. However, diversifying your holdings with Abbott Laboratories or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.8. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Please continue to Trending Equities.
The Abbott Laboratories stock analysis report makes it easy to digest most publicly released information about Abbott Laboratories and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Abbott Stock analysis module also helps to analyze the Abbott Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency.

Abbott Stock Analysis Notes

About 76.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 13th of October 2022. Abbott Laboratories had 10000:4798 split on the 2nd of January 2013. Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. For more info on Abbott Laboratories please contact Miles White at 224 667 6100 or go to

Abbott Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Abbott Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Abbott Laboratories generated a negative expected return over the last 90 days
Over 76.0% of the company shares are held by institutions such as insurance companies
On 15th of November 2022 Abbott Laboratories paid $ 0.47 per share dividend to its current shareholders
Latest headline from Abbott Laboratories stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Abbott Laboratories Upcoming and Recent Events

Earnings reports are used by Abbott Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Abbott Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report26th of January 2022
Next Financial Report19th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End26th of January 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Abbott Largest EPS Surprises

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Abbott Laboratories SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Abbott Laboratories prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Abbott Laboratories investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Abbott Laboratories specific information freely available to individual and institutional investors to make a timely investment decision.
15th of September 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
20th of July 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
2nd of May 2022
Submission of Matters to a Vote of Security Holders
20th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
22nd of February 2022
Financial Statements and Exhibits. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year
18th of February 2022
Regulation FD Disclosure

Abbott Laboratories Thematic Classifications

In addition to having Abbott Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Addiction driven consumer products and services
SRI Sustainable Growth
Large and mid-sized companies that operate under the guidelines of socially responsible investing - SRI
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Drug manufacturing and delivery

Abbott Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 181.09 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Abbott Profitablity

Abbott Laboratories' profitability indicators refer to fundamental financial ratios that showcase Abbott Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Abbott Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Abbott Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Abbott Laboratories' profitability requires more research than a typical breakdown of Abbott Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.18 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.23 %, which entails that for every 100 dollars of revenue, it generated 0.0 of operating income.
Last ReportedProjected for 2022
Return on Investment 15.99  14.55 
Return on Average Assets 9.57  8.64 
Return on Average Equity 20.62  18.92 
Return on Invested Capital 0.26  0.21 
Return on Sales 0.20  0.18 

Management Efficiency

The entity has Return on Asset of 0.0882 % which means that on every $100 spent on asset, it made $0.0882 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 22.5088 %, implying that it generated $22.5088 on every 100 dollars invested. Abbott Laboratories management efficiency ratios could be used to measure how well abbott laboratories manages its routine affairs as well as how well it operates its assets and liabilities. Return on Investment is likely to drop to 14.55 in 2022. Return on Average Assets is likely to drop to 8.64 in 2022. Abbott Laboratories Current Liabilities is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Current Liabilities of 13.11 Billion in 2021. Liabilities Non Current is likely to gain to about 26.6 B in 2022, whereas Total Liabilities is likely to drop slightly above 34.8 B in 2022.
Last ReportedProjected for 2022
Book Value per Share 20.30  20.34 
Enterprise Value over EBIT 30.00  35.79 
Enterprise Value over EBITDA 21.00  20.81 
Price to Book Value 6.91  5.94 
Tangible Assets Book Value per Share 22.10  19.94 
Enterprise Value258 B207.3 B
Tangible Asset Value39.2 B34.2 B
Long Term Debt Total
17.3 B
Non Current Liabilities Total
26.1 B
Forward Dividend Yield
Short Long Term Debt Total
19 B
Forward Dividend Rate
Interest Expense
533 M

Technical Drivers

As of the 7th of December, Abbott Laboratories shows the mean deviation of 1.34, and Risk Adjusted Performance of 0.0463. Abbott Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Abbott Laboratories, which can be compared to its rivals. Please confirm Abbott Laboratories information ratio, and the relationship between the downside deviation and value at risk to decide if Abbott Laboratories is priced correctly, providing market reflects its regular price of 104.81 per share. Given that Abbott Laboratories has jensen alpha of (0.019887), we suggest you to validate Abbott Laboratories's prevailing market performance to make sure the company can sustain itself at a future point.

Abbott Laboratories Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Abbott Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Abbott Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Abbott Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abbott Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abbott Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abbott Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joseph Manning over three months ago via Macroaxis 
Exercise or conversion by Joseph Manning of 23008 shares of Abbott Laboratories subject to Rule 16b-3
Joseph Manning over three months ago via Macroaxis 
Sale by Joseph Manning of 23008 shares of Abbott Laboratories
Mary Moreland over three months ago via Macroaxis 
Abbott Laboratories exotic insider transaction detected
Daniel Starks over three months ago via Macroaxis 
Abbott Laboratories exotic insider transaction detected
Patricia Gonzalez over three months ago via Macroaxis 
Acquisition by Patricia Gonzalez of 303 shares of Abbott Laboratories subject to Rule 16b-3
Lisa Earnhardt over three months ago via Macroaxis 
Payment of 19592 shares by Lisa Earnhardt of Abbott Laboratories subject to Rule 16b-3
John Ginascol over six months ago via Macroaxis 
Payment of 1768 shares by John Ginascol of Abbott Laboratories subject to Rule 16b-3
Randel Woodgrift over six months ago via Macroaxis 
Exercise or conversion by Randel Woodgrift of 24000 shares of Abbott Laboratories subject to Rule 16b-3
Patricia Gonzalez over six months ago via Macroaxis 
Acquisition by Patricia Gonzalez of 1602 shares of Abbott Laboratories subject to Rule 16b-3
Robert Ford over six months ago via Macroaxis 
Payment of 26579 shares by Robert Ford of Abbott Laboratories subject to Rule 16b-3
Randel Woodgrift over six months ago via Macroaxis 
Abbott Laboratories exotic insider transaction detected
Michael Dale over six months ago via Macroaxis 
Sale by Michael Dale of 4000 shares of Abbott Laboratories

Abbott Laboratories Outstanding Bonds

Abbott Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abbott Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abbott bonds can be classified according to their maturity, which is the date when Abbott Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Abbott Laboratories Technical and Predictive Indicators

Abbott Laboratories Forecast Models

Abbott Laboratories time-series forecasting models is one of many Abbott Laboratories' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abbott Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Abbott Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abbott Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abbott shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Abbott Laboratories. By using and applying Abbott Stock analysis, traders can create a robust methodology for identifying Abbott entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 19.56  18.69 
EBITDA Margin 28.41  24.56 
Gross Margin 56.97  63.19 
Profit Margin 16.42  15.50 

Current Abbott Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abbott analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Abbott Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to Abbott conference calls.
Abbott Analyst Advice Details

Abbott Stock Analysis Indicators

Abbott Laboratories stock analysis indicators help investors evaluate how Abbott Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Abbott Laboratories shares will generate the highest return on investment. By understating and applying Abbott Laboratories stock analysis, traders can identify Abbott Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow6838000000.00
Logo U R LimglogosUSAbt.png
Common Stock Shares Outstanding1786000000.00
Total Stockholder Equity35802000000.00
DescriptionAbbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments Established Pharmaceutical Products, Diag
Total Cashflows From Investing Activities-2008000000.00
Tax Provision1140000000.00
Quarterly Earnings Growth Y O Y-0.308
Property Plant And Equipment Net8959000000.00
Retained Earnings31528000000.00
Cash And Short Term Investments10249000000.00
Retained Earnings Total Equity31528000000.00
Accounts Payable4408000000.00
Net Debt9207000000.00
50 Day M A101.4102
Total Current Liabilities13105000000.00
Currency CodeUSD
Other Operating Expenses34650000000.00
Non Current Assets Total50957000000.00
Forward Price Earnings24.4499
Common Stock Total Equity24470000000.00
Please continue to Trending Equities. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
181.1 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.